4.6 Article

Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Half a century of global decline in oceanic sharks and rays

Nathan Pacoureau et al.

Summary: Overfishing is the primary cause of marine defaunation, with global abundance of oceanic sharks and rays declining by 71% since 1970. Three-quarters of the species in this important assemblage are now at risk of extinction. Urgent measures, such as strict fishing prohibitions and science-based catch limits, are needed to prevent further population collapse and promote species recovery.

NATURE (2021)

Review Immunology

World in motion - emulsion adjuvants rising to meet the pandemic challenges

Derek T. O'Hagan et al.

Summary: Emulsion adjuvants like MF59 and AS03 have been widely used in vaccines for over 20 years, showing effectiveness, safety, and ease of manufacturing. They allow for antigen dose sparing, rapid immune responses, and enhanced quality and quantity of adaptive immune responses. These adjuvants induce distinct immunological responses, including a mixed T cell response, long-lived plasma cells, and high titers of cross-neutralizing antibodies.

NPJ VACCINES (2021)

Article Immunology

Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy

Mayuresh M. Abhyankar et al.

Summary: Amebiasis, caused by Entamoeba histolytica, results in approximately 55,000 deaths and millions of infections globally each year. Children and travelers are at highest risk of infection. There are currently no licensed vaccines for prevention of amebiasis.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Synthetic Biology-derived triterpenes as efficacious immunomodulating adjuvants

Mizuki Tateno et al.

SCIENTIFIC REPORTS (2020)

Article Plant Sciences

Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family

Christopher B. Fox et al.

PHYTOMEDICINE (2019)

Article Food Science & Technology

Chemical composition of cold pressed Brazilian grape seed oil

Fernanda Branco Shinagawa et al.

FOOD SCIENCE AND TECHNOLOGY (2018)

Article Multidisciplinary Sciences

Rewriting yeast central carbon metabolism for industrial isoprenoid production

Adam L. Meadows et al.

NATURE (2016)

Article Biophysics

In vitro evaluation of TLR4 agonist activity: Formulation effects

Ayesha Misquith et al.

COLLOIDS AND SURFACES B-BIOINTERFACES (2014)

Review Microbiology

Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development

Chris J. Paddon et al.

NATURE REVIEWS MICROBIOLOGY (2014)

Review Immunology

The history of MF59 (R) adjuvant: a phoenix that arose from the ashes

Derek T. O'Hagan et al.

EXPERT REVIEW OF VACCINES (2013)

Review Immunology

An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants

Christopher B. Fox et al.

EXPERT REVIEW OF VACCINES (2013)

Article Infectious Diseases

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy

Christopher B. Fox et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)

Article Multidisciplinary Sciences

High-level semi-synthetic production of the potent antimalarial artemisinin

C. J. Paddon et al.

NATURE (2013)

Article Pharmacology & Pharmacy

Immunomodulatory and Physical Effects of Phospholipid Composition in Vaccine Adjuvant Emulsions

Christopher B. Fox et al.

AAPS PHARMSCITECH (2012)

Article Pharmacology & Pharmacy

Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions

Christopher B. Fox et al.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2011)

Review Medicine, Research & Experimental

Terpenoids: Opportunities for biosynthesis of natural product drugs using engineered microorganisms

Parayil Kumaran Ajikumar et al.

MOLECULAR PHARMACEUTICS (2008)